MIRM.NASDAQMirum Pharmaceuticals, INC

Form 4: Mirum Pharmaceuticals SVP Jolanda Howe Reports Stock Transactions

Sentiment:

SEC Form 4

📋All filings for Mirum Pharmaceuticals, INC
🔒Login to Follow

Jolanda Howe, SVP, Global Controller of Mirum Pharmaceuticals, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

  • On January 31, 2025, Jolanda Howe, SVP, Global Controller of Mirum Pharmaceuticals, vested 1,772 restricted stock units, each representing one share of common stock.
  • Following the vesting, Ms. Howe sold 1,064 shares of common stock on February 3, 2025, at a price of $48.2225 per share.
  • The sale was conducted to cover tax withholding obligations associated with the vesting of the restricted stock units.
  • After these transactions, Ms. Howe directly owns 4,232 shares of Mirum Pharmaceuticals common stock and 1,771 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an officer, which is neutral in sentiment.

Future Outlook

The remaining 1,771 restricted stock units will vest on January 31, 2026.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the trading activities of company executives.

Stakeholder Impact

  • The transactions have a minimal impact on shareholders as they represent a small percentage of the total outstanding shares.

Key Dates

DateDescription
January 31, 20241,772 restricted stock units vested.
January 31, 20251,772 restricted stock units vested.
January 31, 2026Remaining 1,771 restricted stock units will vest.
January 31, 2025Vesting of 1,772 restricted stock units.
February 3, 2025Sale of 1,064 shares at $48.2225 per share.
February 4, 2025Date of filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.